Herein, we investigated the hyper-serotonergic hypothesis for the pathophysiology of ME/CFS through the utilization of a series of mouse models treated with a SSRI, a 5-HT synthesis inhibitor, and a viral vector for 5-HT1A knockdown. This evidence concerns the gene HTR1A and myalgic encephalomeyelitis/chronic fatigue syndrome.